Zydus Cadila begins human trials for its Covid-19 vaccine candidate

ZyCoV-D will be second Indian-origin vaccine candidate to go into human trials.

The human trials for an indigenous Covid-19 vaccine are closer to the finishing line. 

On Wednesday, Ahmedabad-based Zydus Cadila said it has commenced human trials (Phase 1 and 2) for its deoxyribonucleic acid (DNA) plasmid vaccine ZyCoV-D. 

Meanwhile, Bharat Biotech’s Covaxin human trials, too, have begun. According to the Clinical Trials Registry-India, the estimated timeline for Covaxin trials (Phase 1 and 2) is one year and three moths. Experts feel it will be sooner than estimated.

Panacea Biotec is working on an inactivated whole virus vaccine candidate. Its Managing Director Rajesh Jain said the global generic and specialty pharmaceutical and vaccine maker aims